Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’ll have to disagree on the use of the term “spinning” with regard to my observations — that’s not where I’m coming from. If you review my posts, you can see I’m not a cheerleader.
Your point about the volume in the last half hour is valid — today isn’t any kind of breakout day and if that was the only thing going on it wouldn’t have been worth noting. However, the price action was positive over the last half of the day as I mentioned, not just the last half hour. The price closed near the year’s high, also noteworthy.
Additionally, I pointed out the price action over the last 18 months as having positive elements, which I find to be more significant. For whatever combination of neural firing patterns, I “decided” to share this longer term view, which I’ve been aware of for a while, in the context of day’s price action.
Nice rise in the later half of the day, I like the close near the high too.
Also, over the last 18 months or so, we’ve had a series of higher lowers.
Perhaps the start of a series of higher highs?
Tryn, don’t forget the dash next time!
Riiight. That must be why the price always craters on a dilutive financing. Good hypothesis though.
GGB, I apologize, my writing can be unclear — I have yet to master the art of the single entendre, let alone the fabled triple entendre!
I believe we’re on the same page. He’s a menace. This post gives some of my thoughts on his analysis:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147163852
It’s a little long. I’m more suited to running in the Belmont vs the Kentucky Derby.
Thanks for all the links!!
Do you think his articles, in conjunction with the hammering NWBO’s share price has suffered, has had any impact on their ability to move forward with Direct trials? This question doesn’t assume illegal coordination with short selling. Just the effects of the articles.
I’m asking with regard to it as a separate factor, other than any perceived incompetence or financial shenanigans the company is alleged to have engaged in.
He doesn’t have to be convinced by the blended data — there’s plenty of caveats to go around there. There’s no need for a definitive conclusion— it is blinded after all.
I think his job is to provide a non-biased, intelligent, informed analysis.
But I could be wrong on that. Seems like his job responsibilities, as reflected through his writing, is different from that.
Agreed that it doesn’t tie well into the NWBO is a scam argument. The money they’re paying Innis would ultimately end up in their pockets longer term. It doesn’t refute the argument, I just don’t feel it supports it.
BTW, the fact that I’ve replied to two of your posts today is some kind of coincidence. No conspiracy brewing behind the scenes.
Spot on — If you worked for a ad agency, you’d be made partner after the sales results came back.
Part 2 - Al4door says
Part 1 - Al4door says
Regarding Optune ads
First, it seems to go away on google after you’ve searched for DCVax-L several times (I reproduced Flipper’s experience). That makes sense assuming google has optimized its algorithm in certain ways. There’s probably an optimum number of ad impressions before diminishing returns kick in.
Second, as Biosect points out and I experienced as well, it started showing up after the Optune conversation on this board. Google could be tracking what we read, though multiple ways. Or perhaps some of us did some google searches regarding Optune in response to the conversation here. A test of that would be for those who know they never did a search for Optune to try a search for DCVax-L to see if you get the ad. I’m pretty sure I did at least one search of Optune in the last couple of weeks.
Joe Rogan told of a personal experience related to tracking across multiple platforms that was particularly creepy. He and his friends were talking about a specific Jean-Claude Van Damm movie from the ‘80’s one afternoon. Later that night, back at home, Joe logged onto Netflix. Several Van Damm movies were recommended to him. He contends the only way that would have happened is if his phone had been monitoring his conversation because he hadn’t done anything in the intervening time to trigger that result other than talk about an obscure movie with friends a few hours before.
That one’s phone is listening to conversations and parsing for keywords and updating a database somewhere is certainly feasible. And given the fact that assholes like Mark “Privacy is dead” Zuckerberg have such prominent roles in technology these days, it’s likely to be the case that some app on your phone is doing that. It’s one of many reasons why I don’t download any apps on my phone. Paranoid? Knowledgeable? Both?
However, an equally likely way to explain Joe’s experience that is somewhat less creepy and could be more easily justified to the public if it got out would be for ads to be also based on our close network of friends and family. One of his friends in the conversation probably googled the movie even though he didn’t. Netflix no doubt buys marketing data from google since it is one of the best sources of information on us in the world. Netflix’s algorithm probably uses friends’ profiles to predict what you might like. This makes a lot of sense based on social network research. Even some friends of friends can be highly predictive of some of our traits and preferences.
Of course it’s possible that Joe’s Van Damm experience and Optune starting to advertise on social media after the conversation here are both coincidences. Perhaps we are more attuned to seeing the word Optune after the last couple of weeks. This would fit if it’s only due to Optune’s use of AdWords/Adsense of whatever it’s called.
I think some kind of data mining/sharing is likely however.
Thanks for your perspective, Ex! The use of “mutated” was a nice touch!
I’m interested in tracking down the original use and subsequent mutation as general use/mockery. Is this a widely known reference or is it more restricted to NWBO junkies? It seems like it occasionally comes up on AFs Twitter feed since I believe I saw it there at least once.
Man I am out of it - I thought she was still on the board. Did she leave because of her illness?
And yes, I agree she would have used DCVax-L if she could. It would be interesting to know the details around all that.
Doc, anybody else, I’ve been meaning to ask about the grapefruit juice comment — do you know where the first instance of that appeared? I’ve tried three times to find it but have been unsuccessful. I thought I read that it was in the comments of a seekingalpha article and that someone here (you perhaps?) was who responded to with his acerbic wit.
The Bayhs then decided to seek treatment at Duke Medical Center in Durham, North Carolina. The doctors arranged for immunotherapy, chemotherapy and 33 days of radiation treatments.
https://www.wthr.com/article/exclusive-family-finds-strength-and-hope-after-susan-bayhs-cancer-diagnosis
Doesn’t sound like she went with DCVax, maybe she chose the Jimmy Carter treatment (pembrolizumab/keytruda). I know I’m leaving one hanging over the plate. Who will hit it into the stands?
https://www.cancerresearch.org/join-the-cause/cancer-immunotherapy-month/30-facts/20
Thanks - appreciate the additional thoughts and detail (eg, the filings) around this!
It is telling that Dr Horton and Dr Angell, former editors of two of the most prestigious medical journals, wrote books decrying the corruption of medicine as soon as they left their posts.
Here are two more — seems to be a growing cottage industry:
Dr Jerome Kassirer, former Editor-in-Chief of The New England Journal of Medicine and
Dr Richard Smith, a previous editor of the British Medical Journal for twenty five years.
https://www.amazon.com/Take-Medicines-Complicity-Business-Endanger/dp/0195176847/ref=mp_s_a_1_fkmrnull_1
https://www.amazon.com/Trouble-Medical-Journals-Richard-Smith/dp/1853156736/ref=mp_s_a_1_fkmrnull_1
Here’s a snippet of a review of Smith’s book:
Appreciate the extended reply — a couple of things to chew on (propaganda and buy out) and digest.
The lack of a Wells letter seems telling, as you point out. How do you think this might finally get put to bed? Will the SEC issue some kind of finding or statement saying “Nothing to see here” if they do not issue a Wells letter?
Meet Elizabeth Bik, who has identified more than a thousand fraudulent images in scientific journals (in her spare time no less).
https://www.lastwordonnothing.com/2019/02/12/the-western-blot-vigilante/
It would seem that there should be a way out of limbo, since the cloud of wrongdoing hanging over the company could scare off investors, but I’m no expert on the SEC nor am I Catholic.
Susan Bayh, former Indiana first lady, undergoes surgery for malignant brain cancer
https://www.google.com/amp/s/amp.indystar.com/amp/633034002
Not sure if this has been posted before (story is from May 23, 2018). Came across it following up some loose threads from previous posts.
JR, LF, Less and Senti — Appreciate your insights and info provided - Thanks!
That it might be “winding to a conclusion” adds another random news event of potential significance in the months ahead.
Ex, I don’t have to go to google to figure it out. Bayh = Indiana = Ely Lilly. I know Indiana politics (Politics is my fucking bad habit, among others).
Have you thought deeper about what’s going on here? If not, why? You’re a smart guy.
Lol — it’s so effective you can get inflammatory arthritis if you’re in the same clinic as someone who gets an ICI infusion but you don’t — it’s that potent!
Life of Brian — brilliant — hard to top!
The Python scene I’ve come back to regularly kind of applies to that long list of AEs putting “a gloom over the evening:”
LF, thanks for the list! I thought about asking the board but am loath to when I can dig for myself
It’s a little worse than that— ICIs seem to cause rheumatoid arthritis in some people:
immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen
More on AEs. Rago originally tweeted this.
https://www.sciencedirect.com/science/article/pii/S0049017218300428
Introduction
Immune checkpoint inhibitors (ICIs) are a class of cancer immunotherapy, increasingly utilized to treat malignancies. Inflammatory arthritis (IA) is a potential consequence of ICI use, but there is limited information to guide evaluation and management of this immune-related adverse event (irAE). This study aimed to characterize clinical phenotypes, IA treatment and response in the largest cohort of patients with ICI-induced IA reported to date.
Methods
Patients with rheumatologist-confirmed IA occurring during or after ICI treatment with no prior history of autoimmune disease were included. Data were analyzed by ICI treatment regimen; treatments included combination CTLA-4/PD-1 inhibition, anti-PD-1 or anti-PD-L1 monotherapy. Relationship to the development of other irAEs, management of IA, and outcomes of IA management were evaluated.
Results
Of 30 patients identified, those treated with combination ICI therapy were more likely to present with knee arthritis, to have higher levels of C-reactive protein, to have already had another irAE, and to have a reactive arthritis-like phenotype. In contrast, patients treated with ICI monotherapy were more likely to have initial small joint involvement and to have IA as their only irAE. Ten patients required additional immunosuppression beyond corticosteroids, with TNF-inhibitors and/or methotrexate. Tumor progression while on non-corticosteroid immunosuppression was not seen in those with initial tumor response to ICIs.
Conclusion
These data suggest that distinct IA phenotypes may emerge with exposure to different ICI regimens. The majority of patients referred to rheumatology required systemic immunosuppression to manage their IA symptoms. Tumor progression was not seen in patients requiring TNF-inhibitors.
Reg, I think I found it
http://www.cityam.com/273320/stobart-battle-judge-finds-former-boss-andrew-tinkler
Woodford isn’t mentioned in the judge’s ruling, presumably because of the failure to establish a conspiracy to topple the board.
And an earlier story on Woodford’s shock at the shenanigans/accusations:
http://www.cityam.com/269361/star-trader-neil-woodford-shocked-stobart-conspiracy
Are you thinking this, Reg?
“Once is happenstance. Twice is coincidence. Three times is enemy action.”
Ian Fleming
Hi Reg, looks like google’s bots haven’t trawled the Bloomberg source you mentioned yet or something (like my search skills are deteriorating with age) because I can’t find anything related to your post. Could you post a reference or provide some more details?
Thanks!